Brawn Biotech
Brawn Biotech Share Price Chart
Brawn Biotech last traded at ₹24.50 (2026-10-13). Over the past month the stock moved +5.2%, three months the stock moved +21.7%, year the stock moved +17.8%. Its closing range over 52 weeks is ₹18.51 – ₹25.50, with the latest close 3.9% below the high.
Closing prices up to 2026-10-13.
About Brawn Biotech
Incorporated in 1985, Brawn Biotech Ltd is in the business of trading pharmaceutical products[1]
Business Overview:[1] BBL is a fully integrated healthcare company that deals in pharmaceutical products, covering segments: a) Antibacterial b) Cardiovascular c) Antidiabetics d) Analgesics e) Gastrointestinal f) Antifungals g) Skin Care h) Antipsychotics, i) Anti-asthmatics j) Antacids k) Antimalarial l) Nutritional
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Brawn Biotech reported sales of ₹6.08 crore (+4.8%) and net profit of ₹0.15 crore (-37.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 6.08 | 0.04 | 0.66 | 0.15 | 0.50 |
| Mar 2026 | 1.98 | -0.51 | -25.76 | 0.58 | 1.93 |
| Dec 2025 | 4.31 | -0.01 | -0.23 | 0.05 | 0.17 |
| Sep 2025 | 4.89 | 0.01 | 0.20 | 0.07 | 0.23 |
| Jun 2025 | 5.80 | 0.18 | 3.10 | 0.24 | 0.80 |
| Mar 2025 | 2.26 | -0.55 | -24.34 | -0.49 | -1.63 |
| Dec 2024 | 3.84 | -0.40 | -10.42 | -0.43 | -1.43 |
| Sep 2024 | 3.30 | -0.32 | -9.70 | -0.34 | -1.13 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +13.0% | +35.2% | -34.5% | +42.9% | +48.2% | +12.2% | -12.4% | +4.8% |
| Operating profit growth | – | – | – | – | – | – | – | -77.8% |
| Net profit growth | – | – | – | – | – | – | – | -37.5% |
| EPS growth | – | – | – | – | – | – | – | -37.5% |
| OPM % | -9.7% | -10.4% | -24.3% | 3.1% | 0.2% | -0.2% | -25.8% | 0.7% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Brawn Biotech reported sales of ₹16.98 crore (+26.1%) and net profit of ₹0.94 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 16.98 | -0.33 | -1.94 | 0.94 | 3.13 |
| Mar 2025 | 13.47 | -1.77 | -13.14 | -1.80 | -6.00 |
| Mar 2024 | 16.49 | -1.46 | -8.85 | -1.25 | -4.17 |
| Mar 2023 | 22.23 | -0.30 | -1.35 | -0.87 | -2.90 |
| Mar 2022 | 8.53 | -2.00 | -23.45 | -1.64 | -5.47 |
| Mar 2021 | 34.98 | -0.60 | -1.72 | -0.55 | -1.83 |
| Mar 2020 | 49.62 | 0.73 | 1.47 | 0.59 | 1.97 |
| Mar 2019 | 65.18 | 1.17 | 1.80 | 1.33 | 4.43 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +17.0% | -23.9% | -29.5% | -75.6% | +160.6% | -25.8% | -18.3% | +26.1% |
| Operating profit growth | -40.3% | -37.6% | -182.2% | – | – | – | – | – |
| Net profit growth | +3.9% | -55.6% | -193.2% | – | – | – | – | – |
| EPS growth | +3.7% | -55.5% | -192.9% | – | – | – | – | – |
| OPM % | 1.8% | 1.5% | -1.7% | -23.5% | -1.4% | -8.9% | -13.1% | -1.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Brawn Biotech.
Get Free AI Stock Analysis FREE →Latest News
-
Brawn Biotech passes all resolutions at 41st AGM held virtually - scanx.trade
Frequently Asked Questions
What is the share price of Brawn Biotech today?
Brawn Biotech shares were last quoted at ₹24.50 (-3.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Brawn Biotech?
Brawn Biotech has a price-to-earnings (P/E) ratio of 7.71 and a price-to-book (P/B) ratio of 1.47. The industry P/E is 53.45.
What is the 52-week high and low of Brawn Biotech?
The 52-week high of Brawn Biotech is ₹24.37 and the 52-week low is ₹17.71.
What is the market cap of Brawn Biotech?
The market capitalisation of Brawn Biotech is about ₹6.62 crore.
How did Brawn Biotech perform in its latest quarterly results?
In the latest quarter (Jun 2026), Brawn Biotech reported sales of ₹6.08 crore (+4.8%) and net profit of ₹0.15 crore (-37.5%), compared with the same quarter last year.
Is Brawn Biotech a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Brawn Biotech has a 3-year ROE of -15.00%, 3-year profit growth of 46.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Brawn Biotech?
Promoters hold about 52.94% of Brawn Biotech.
Which sector does Brawn Biotech belong to?
Brawn Biotech belongs to the Pharmaceuticals & Drugs sector.